Schedule 13G ownership disclosure

Zomedica Pharmaceuticals Corp.

Security class unavailable · CUSIP: 98979F107

Event date: 2018-06-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,751,861
Percent of class
6.0900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001437749-18-017205
Form type
SC 13G
Filer
EQUIDEBT LLC
CIK
CIK 1753306
Filed
Sep 19, 2018
Reporting period
Jun 28, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub